AU3216693A - Rna and dna molecules for producing virus resistance - Google Patents

Rna and dna molecules for producing virus resistance

Info

Publication number
AU3216693A
AU3216693A AU32166/93A AU3216693A AU3216693A AU 3216693 A AU3216693 A AU 3216693A AU 32166/93 A AU32166/93 A AU 32166/93A AU 3216693 A AU3216693 A AU 3216693A AU 3216693 A AU3216693 A AU 3216693A
Authority
AU
Australia
Prior art keywords
rna
dna molecules
virus resistance
producing virus
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32166/93A
Inventor
Peter Dr Loss
Edgar Dr Maiss
Rudolf Dr Schneider
Peter Dr Schreier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Hoechst AG
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Bayer AG
Hoechst AG
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Hoechst AG, Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Bayer AG
Publication of AU3216693A publication Critical patent/AU3216693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU32166/93A 1992-02-06 1993-02-02 Rna and dna molecules for producing virus resistance Abandoned AU3216693A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4203441 1992-02-06
DE4203441A DE4203441C1 (en) 1992-02-06 1992-02-06 RNA and DNA molecules to create virus resistance

Publications (1)

Publication Number Publication Date
AU3216693A true AU3216693A (en) 1993-08-12

Family

ID=6451102

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32166/93A Abandoned AU3216693A (en) 1992-02-06 1993-02-02 Rna and dna molecules for producing virus resistance

Country Status (4)

Country Link
EP (1) EP0558944A3 (en)
JP (1) JPH0690758A (en)
AU (1) AU3216693A (en)
DE (1) DE4203441C1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685428B2 (en) * 1993-01-29 1998-01-22 Cornell Research Foundation Inc. Tomato spotted wilt virus
US6818804B1 (en) 1999-10-22 2004-11-16 Cornell Research Foundation, Inc. Tospovirus resistance in plants

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1288296A3 (en) * 1992-05-11 2003-03-12 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting HBV viral replication
US6469158B1 (en) 1992-05-14 2002-10-22 Ribozyme Pharmaceuticals, Incorporated Synthesis, deprotection, analysis and purification of RNA and ribozymes
CA2135646A1 (en) * 1992-05-11 1993-11-25 Kenneth G. Draper Method and reagent for inhibiting viral replication
US5804683A (en) * 1992-05-14 1998-09-08 Ribozyme Pharmaceuticals, Inc. Deprotection of RNA with alkylamine
US5610054A (en) * 1992-05-14 1997-03-11 Ribozyme Pharmaceuticals, Inc. Enzymatic RNA molecule targeted against Hepatitis C virus
US5972699A (en) 1992-05-14 1999-10-26 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting herpes simplex virus replication
RU94046396A (en) * 1992-06-29 1996-11-10 Джин Ширс Пти.Лтд. (AU) Nucleic acid, dna, vector, method of plant or animal preparing, method of cell preparing, method of animal constructing, animal, transgenic animal, transgenic plant, fruits, cuttings and seeds, vegetable cells, method of interference to virus replication
US5891684A (en) * 1992-10-15 1999-04-06 Ribozyme Pharmaceuticals, Inc. Base-modified enzymatic nucleic acid
JPH09505461A (en) * 1993-07-22 1997-06-03 ジーン シェアーズ プロプライアタリー リミティド DNA virus ribozyme
CA2176035A1 (en) 1993-11-08 1995-05-18 Nassim Usman Base-modified enzymatic nucleic acid
US6107027A (en) * 1994-12-14 2000-08-22 University Of Washington Ribozymes for treating hepatitis C
EP0914421A2 (en) * 1996-02-29 1999-05-12 Immusol, Inc. Hepatitis c virus ribozymes
AR020329A1 (en) * 1998-07-09 2002-05-08 Boehringer Ingelheim Pharma A SUBSTANCE, IN PARTICULAR A RIBOZIMA, IS ABLE TO INHIBIT THE PRESENILINE EXPRESSION 2, A RECOMBINATING MOLECULA OF DNA THAT CODIFY SUCH RIBOZIMA, A RECOMBINATING UNVECTOR THAT UNDERSTANDS THE CORRECTING CELL TO A RIBO BELLING ONE.
BR0209181A (en) 2001-04-24 2004-08-24 Cornell Res Foundation Inc Synthetic nucleic acid molecule for multiple traits
WO2007058323A1 (en) * 2005-11-17 2007-05-24 Napa Jenomics Co., Ltd. Method for production of nucleic acid homopolymer-bound functional nucleic acid medicine
JPWO2007058323A1 (en) * 2005-11-17 2009-05-07 Ｎａｐａ Ｊｅｎｏｍｉｃｓ 株式会社 Method for producing nucleic acid homopolymer-binding functional nucleic acid pharmaceutical
EP4082332A4 (en) 2019-12-24 2024-01-24 Kikkoman Corporation Solanaceous plant and solanaceous plant cell having resistance to tomato spotted wilt virus, and method for producing solanaceous plant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225347A (en) * 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Therapeutic ribozyme compositions and expression vectors
DE3933384A1 (en) * 1989-10-06 1991-04-18 Hoechst Ag MULTIFUNCTIONAL RNA WITH SELF-PROCESSING ACTIVITY, THEIR PRODUCTION AND THEIR USE
HUT57265A (en) * 1989-11-03 1991-11-28 Zaadunie Bv Process for producing plants of diminished infection-sensitivity
WO1992006693A1 (en) * 1990-10-22 1992-04-30 Fox Chase Cancer Center Dna construct for providing rna therapy

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685428B2 (en) * 1993-01-29 1998-01-22 Cornell Research Foundation Inc. Tomato spotted wilt virus
US6329568B1 (en) 1993-01-29 2001-12-11 Cornell Research Foundation, Inc. Tospovirus resistance in plants
US6818804B1 (en) 1999-10-22 2004-11-16 Cornell Research Foundation, Inc. Tospovirus resistance in plants

Also Published As

Publication number Publication date
JPH0690758A (en) 1994-04-05
EP0558944A2 (en) 1993-09-08
EP0558944A3 (en) 1994-06-08
DE4203441C1 (en) 1993-10-14

Similar Documents

Publication Publication Date Title
AU3216693A (en) Rna and dna molecules for producing virus resistance
AU4802896A (en) Phosphonomonoester nucleic acids, process for their preparation, and their use
AU2201095A (en) Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
AU4803196A (en) Recombinant DNA virus and method for preparation thereof
HUP9801216A3 (en) Dna molecules, preparation thereof and use thereof in gene therapy
AU4049589A (en) Rna and dna amplification techniques
AU7978694A (en) Catalytic dna
IL110406A0 (en) DNA virus ribozymes
AU1566595A (en) Method and reagent for inhibiting hepatitis c virus replication
AU1209897A (en) Novel dna polymerase
AU4911496A (en) Multiple component rna catalysts and uses thereof
EP0964930A4 (en) Catalytic rna molecules
AU2317095A (en) Dna sequences
AU7623194A (en) Oligonucleotides with rna cleavage activity
AU6057296A (en) DNA sequencing and DNA terminators
AU5874798A (en) Vaccination methods and molecules
AU654662B2 (en) Virus/herbicide resistance genes process for producing same and their use
AU3979395A (en) DNA sequences and their use
AU4550896A (en) New DNA molecules
AU3470195A (en) Nucleic acid fragment and products derived therefrom
AU5974194A (en) Oligonucleotides with rna cleavage activity
AU5800996A (en) Nes-1 polypeptides, dna, and related molecules and methods
AU1457992A (en) Pcr generated dicistronic dna molecules for producing antibodies
AU5369396A (en) Rest protein and dna
AU6221996A (en) Oligonucleotides specific for hepatitis c virus